Direct synthesis of lamin A, bypassing prelamin a processing, causes misshapen nuclei in fibroblasts but no detectable pathology in mice.
about
Targeting protein prenylation in progeriaBlocking protein farnesylation improves nuclear shape abnormalities in keratinocytes of mice expressing the prelamin A variant in Hutchinson-Gilford progeria syndromeBreaching the nuclear envelope in development and diseaseMouse models of laminopathiesThe effect of the lamin A and its mutants on nuclear structure, cell proliferation, protein stability, and mobility in embryonic cellsThe interaction between nesprins and sun proteins at the nuclear envelope is critical for force transmission between the nucleus and cytoskeleton.Farnesylation of lamin B1 is important for retention of nuclear chromatin during neuronal migration.Nuclear lamins and neurobiology.Chromatin remodeling, DNA damage repair and aging.Absence of progeria-like disease phenotypes in knock-in mice expressing a non-farnesylated version of progerin.An absence of nuclear lamins in keratinocytes leads to ichthyosis, defective epidermal barrier function, and intrusion of nuclear membranes and endoplasmic reticulum into the nuclear chromatinInvestigating the purpose of prelamin A processingAn absence of both lamin B1 and lamin B2 in keratinocytes has no effect on cell proliferation or the development of skin and hair.Deficiencies in lamin B1 and lamin B2 cause neurodevelopmental defects and distinct nuclear shape abnormalities in neuronsRegulation of prelamin A but not lamin C by miR-9, a brain-specific microRNA.Are B-type lamins essential in all mammalian cells?Understanding the roles of nuclear A- and B-type lamins in brain development.Nuclear lamins in the brain - new insights into function and regulation.Modulation of LMNA splicing as a strategy to treat prelamin A diseases.Nuclear lamin functions and disease.Myopathic lamin mutations impair nuclear stability in cells and tissue and disrupt nucleo-cytoskeletal coupling.Lamin B1 and lamin B2 are long-lived proteins with distinct functions in retinal development.Mass spectrometry captures off-target drug binding and provides mechanistic insights into the human metalloprotease ZMPSTE24.New Lmna knock-in mice provide a molecular mechanism for the 'segmental aging' in Hutchinson-Gilford progeria syndrome.Protein farnesylation and disease.Normal and aberrant splicing of LMNA.Do lamin A and lamin C have unique roles?HypE-specific nanobodies as tools to modulate HypE-mediated target AMPylation.MG132-induced progerin clearance is mediated by autophagy activation and splicing regulation.Structure and stability of the lamin A tail domain and HGPS mutant.Depleting the methyltransferase Suv39h1 improves DNA repair and extends lifespan in a progeria mouse model.LMNA missense mutations causing familial partial lipodystrophy do not lead to an accumulation of prelamin A.OGT (O-GlcNAc Transferase) Selectively Modifies Multiple Residues Unique to Lamin A.The Pathogenesis and Therapies of Striated Muscle Laminopathies
P2860
Q24594564-F218F37A-3888-427E-A6C8-50536FFDF78CQ24627329-7D9D7B41-1071-4EB2-8665-81AABADA1DD7Q26823239-AD460858-7EEB-4A2B-B3F5-6287B9722F44Q26829927-809F49F3-8443-46C1-A51A-1AAE7EB99C4CQ28910340-C00A21B9-74A0-401B-A428-271993DF854FQ30502842-E3E5B771-51A6-4279-ADEC-37BF2398469FQ30540136-E346147F-302F-4B40-8C4F-98FB398E7ED6Q34056472-54BCB12A-65B2-4ACF-97D5-459988FFE4F1Q34342179-A7CECDFE-03A3-4814-9AA9-1B78614F7929Q34470636-0F8046C0-EBB3-4338-B37C-4D2D5097FF5AQ34592855-FF931075-07C0-4D3C-B0E2-D17604D2CBB8Q35015891-92692EF0-665D-4DBA-83F1-EE0925BE9B1FQ35175056-BB93504D-1AE2-42B5-9F4F-6DAC20DFD037Q35579834-9BF0A1D5-5E97-4456-A2E0-1651BE58942FQ35787261-3C0C8190-232B-473D-827B-4F3223A6AE16Q35883255-08126015-DF37-4673-B566-EB0DB13199D3Q35956784-AD91AB09-67BD-4942-B173-8B6597111C5CQ36514069-14FBEAF1-957D-4AE1-9A43-FC9A0A687D35Q36737860-294352BE-453E-40D9-9791-C3A4B2DBE445Q36787496-41CF4BF1-78ED-49F7-B7FE-DC1A74A62DDEQ36856331-6D99CEC4-1BFA-4548-8028-19663D6C7A16Q37003859-DDD07DDE-6AF4-47C9-8024-CC7472C7D011Q37441222-2C5EBDD2-9906-4293-8482-227510A5B397Q37593037-99E90956-49C5-400E-82AA-E1F586EFD2ACQ37981563-3588C901-E55F-451E-9C83-0DBDD6A252D4Q38181458-5B42816A-1F86-4B24-8259-EE0E9B29AFD9Q38256841-CE51D005-534C-43CE-8F43-EB246BD66300Q38910073-F8DA2914-53CD-4F16-9B34-9E0D4B7761DDQ41601030-0D3812DD-2521-466A-8098-027B74C8CD77Q42133558-00D5147C-2ED4-4022-BD73-3FFFDD29ED73Q42142108-B3745914-4E17-4E96-B541-6DF16A7D53A4Q43204250-5278E621-4FE1-46F6-A875-36321956B52AQ55364768-C2D7256B-2640-4718-BA88-DFFE7B57D293Q58693707-064DE540-3DA3-447E-8EED-2EFBB4B73B71
P2860
Direct synthesis of lamin A, bypassing prelamin a processing, causes misshapen nuclei in fibroblasts but no detectable pathology in mice.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Direct synthesis of lamin A, b ...... detectable pathology in mice.
@ast
Direct synthesis of lamin A, b ...... detectable pathology in mice.
@en
type
label
Direct synthesis of lamin A, b ...... detectable pathology in mice.
@ast
Direct synthesis of lamin A, b ...... detectable pathology in mice.
@en
prefLabel
Direct synthesis of lamin A, b ...... detectable pathology in mice.
@ast
Direct synthesis of lamin A, b ...... detectable pathology in mice.
@en
P2093
P2860
P356
P1476
Direct synthesis of lamin A, b ...... detectable pathology in mice.
@en
P2093
Brandon S Davies
Catherine Coffinier
Chika Nobumori
Emily A Farber
Hea-Jin Jung
Jan Lammerding
Javad N Farahani
Laurent A Bentolila
Loren G Fong
Michael M Weinstein
P2860
P304
20818-20826
P356
10.1074/JBC.M110.128835
P407
P577
2010-05-03T00:00:00Z